In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pacific Biosciences of California Inc.

www.pacificbiosciences.com

Latest From Pacific Biosciences of California Inc.

Historic Mapping Of Deadly Pathogens Allows PacBio To Showcase Its Platform

PacBio and Wellcome Sanger Institute tell Scrip why they've teamed up to decode genomes of more than 3,000 bacteria, including some of the world's most dangerous, and how it will help fight AMR and bioterrorism.

Platform Technologies Strategy

Illumina Aims For All-Inclusive Cancer Screen Via New Start-Up

Genetic sequencing company Illumina is betting it can develop the first next-generation sequencing "pan-cancer" screening assay by building a separate company dedicated to the task. The new firm has $100 million in start-up funds and is called Grail.

Medical Device Personalized Medicine

Device/Diagnostics Quarterly Deal Statistics, Q4 2014

Q4 device financing reached $902 million versus Q3’s $734 million, while device M&A dollar volume increased $19 billion, from Q3’s $4.9 billion. Diagnostics companies raised $750 million, an 85% rise over the previous quarter’s $405 million; although diagnostics M&A totaled just $1 billion, it was the most deal-active quarter of 2014 with 11 transactions.

Medical Device Deals

Start-Up Quarterly Statistics, Q4 2014

In Q4 2014 start-ups raised $1.5 billion, a new record. Several companies penned alliances with tech transfer entities; eight start-ups were acquired.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Nanotechnology, Chips, etc.
    • Pharmacogenetics-Pharmacogenomics
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Nanofluidics Inc.
  • Pacific Biosciences Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pacific Biosciences of California Inc.
  • Senior Management
  • Michael W Hunkapiller, Pres. & CEO
    Susan K Barnes, EVP, CFO
    Jonas Korlach, PhD, CSO
    Kathy Ordonez, EVP, Chief Commercial Officer
  • Contact Info
  • Pacific Biosciences of California Inc.
    Phone: (650) 521-8000
    1305 O'Brien Dr.
    Menlo Park, CA 94025
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register